HSE accepts new epilepsy drug Briviact for use in Ireland
Tuesday, April 11, 2017The HSE has accepted Briviact (brivaracetam) for use within Ireland as an add-on treatment for partial onset seizures (POS), with or without secondary generalised seizures in adults with epilepsy (aged 16 years and older).